BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference

BillionToOne will join the Wells Fargo 21st Annual Healthcare Conference with a webcast fireside chat available to investors online.

Rhea-AI Summary

BillionToOne (BLLN) announced that its management will participate in the Wells Fargo 21st Annual Healthcare Conference. The team is scheduled for a fireside chat from 2:15pm to 2:50pm Eastern Time on Wednesday, September 9, 2026. A live and archived webcast will be accessible via the Events & Presentations section of the company’s investor relations website.

Market Context

The August 18 clinical-data announcement drew a -6.3% response, while this conference notice adds ti...

Analysis

The August 18 clinical-data announcement drew a -6.3% response, while this conference notice adds timing rather than operating results. Recent insider records showed net selling, a risk factor to monitor.

Key Figures

Conference edition: 21st annual Fireside chat date: September 9, 2026 Fireside chat time: 2:15pm–2:50pm Eastern Time

3 metrics

Conference edition 21st annual Wells Fargo Healthcare Conference

Fireside chat date September 9, 2026 BillionToOne management fireside chat

Fireside chat time 2:15pm–2:50pm Eastern Time September 9, 2026

Historical Context

5 past events · Latest: Sep 01 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Sep 01	Liquid biopsy launch	Positive	+1.8%	Northstar Origin launch reported 87% top-prediction accuracy across 1,578 validation cases.
Aug 18	Clinical study publication	Positive	-6.3%	Prospective Unity study reported 94.4% sensitivity and 99.5% specificity in general-risk pregnancies.
Aug 18	Clinical study correction	Positive	-6.3%	Correction restated Unity study results, including >99.9% negative predictive value and 2,212 carriers.
Aug 05	Second-quarter earnings	Positive	-38.9%	Second-quarter results showed $109.4 million revenue and reiterated 2026 guidance.
Jul 20	Leadership appointment	Neutral	-4.0%	Appointment named Ethan Dmitrovsky as oncology chief medical officer for Northstar strategy.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent history showed divergence on three positive announcements, while one positive launch aligned with a positive price reaction.

Key Terms

molecular diagnostics

1 terms

molecular diagnostics medical

"a next-generation molecular diagnostics company with a mission"

Molecular diagnostics are laboratory tests that look for specific molecules — such as genes, pieces of DNA or RNA, or proteins — to detect disease, predict risk, or guide treatment choices. For investors, these tests matter because they can change how illnesses are diagnosed and treated, create recurring revenue through specialized tests and companion products, and face clear regulatory and reimbursement pathways that drive commercial value; think of them as reading a biological barcode to inform medical decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MENLO PARK, Calif., Sept. 2, 2026 /PRNewswire/ -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the Wells Fargo 21^st Annual Healthcare Conference.

Management will participate in a fireside chat from 2:15pm to 2:50pm Eastern Time on Wednesday, September 9, 2026.

A live and archived webcast will be available on the "Events & Presentations" page of BillionToOne's investor relations website at https://investors.billiontoone.com/news-events/events-presentations.

About BillionToOne

Headquartered in Menlo Park, California, BillionToOne is a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's proprietary single-molecule next-generation sequencing (smNGS) platform is the only multiplex technology that can detect and precisely quantify genetic targets at the physical limit of detection, down to the single DNA molecule. Enabled by Quantitative Counting Templates™ (QCTs™), the platform quantifies disease-related DNA fragments with single base-pair resolution, providing absolute quantification. For more information, visit www.billiontoone.com.

Investor Contact
ir@billiontoone.com

Media Contact
rachel@fordhutmanmedia.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/billiontoone-to-participate-in-the-wells-fargo-21st-annual-healthcare-conference-302868082.html

SOURCE BillionToOne

FAQ

When will BillionToOne (BLLN) present at the Wells Fargo 21st Annual Healthcare Conference?

BillionToOne management will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference from 2:15pm to 2:50pm Eastern Time on Wednesday, September 9, 2026.

How can investors access the BillionToOne (BLLN) webcast for the Wells Fargo healthcare conference?

A live and archived webcast of BillionToOne’s fireside chat will be available on the “Events & Presentations” page of the company’s investor relations website at https://investors.billiontoone.com/news-events/events-presentations.

What type of session will BillionToOne (BLLN) hold at the Wells Fargo 21st Annual Healthcare Conference?

BillionToOne management will take part in a fireside chat during the Wells Fargo 21st Annual Healthcare Conference, scheduled for the afternoon of September 9, 2026.